E-poster Presentation 2014 World Cancer Congress

Incidence, mortality and survival trends of smoking-related cancers in women in Setif, Algeria, 1990-2009. (#790)

Zoubida Zaidi 1 , Mokhtar Hamdicherif 2
  1. University Hospital of Setif, Setif, N/A =, Algeria
  2. Epidemiology, Cancer registry, Setif, Algeria

Background: Tobacco use is the leading preventable cause of disease and premature death, in Algeria and in the world. 

Aim:  to estimate the impact of the tobacco on the cancerous mortality and the morbidity in the wilaya of Setif. 

Methods: Incidence datas, were obtained from the population-based cancer registry of Setif, the sources of information of the cancer mortality were provided of the admission offices of the university hospital and the center for the fight against cancer of Algiers, Constantine. The informations of the cancer survival were obtained by the incidence and the mortality datas, this  file was coupled with the active follow-up of the vital status of the electoral lists and the registers of the civil status of the wilaya.

These cancer sites included in the monograph 100E of the international agency for research on cancer on 2012. The colorectal, the ovary, the breast cancers and the myelogenous leukemia, by adding them to the list of the smoking-related cancers with the significatvely relationship between tobacco use and the following cancers included in the 2004 monograph : oral cavity and  pharyngeal,  esophageal, stomach, liver, pancreatic, laryngeal, lung and bronchial, cervical cancers and kidney, urinary bladder cancers.

Results: from 1990 to 2009, a significantly increase incidence rates , the annual percentage change was (+7, 2%).  On 2001-2005, the cancer survival rates vary between (52, 8%) for breast cancer and 3, 3% for lung cancer.

Conclusions: The change over time in the smoking related cancers incidence of females in Algeria can be explained fairly well by the increase in cumulative cigarette consumption at the national level. Prevention and tobacco control efforts are still needed to further reduce the burden of this disease.